2020-06-10_CvULB.docx Page 1/29
. DE MAERTELAER janvier 2020
CURRICULUM VITAE
I. Informations générales
1.1. Nom, Prénom De Maertelaer, Viviane
1.2. Sexe F
1.3. Lieu et date de naissance Ixelles, le 11.11.1946
1.4. Nationalité Belge
1.5. Adresse du domicile : Rue du Coq 14 à 1380 Lasne 1.6 Téléphone et e-mail Tél. mobile: 32 476 420 556
e-mail : [email protected]
1.7. Connaissance des langues :
- active : français (langue maternelle), anglais, néerlandais - passive : allemand, italien
1.8. Boursière du Fond Belge des Mieux Doués en 1958 pour les études secondaires.
1.9 Vice –Présidente des Jeunesses Scientifiques de Belgique 1961-1964.
1.9 Expertises principales
• Analyses statistiques de données médicales, et notamment d’essais cliniques depuis 1978.
• Maîtrise des logiciels « classiques » (Word, Excel, Powerpoint, Access ...)
• Maîtrise du logiciel statistique IBM-SPSS depuis 1980, du logiciel statistique MEDCALC depuis 2000 du logiciel NCSS, du logiciel PASS13 et du logiciel SAS depuis 2011.
• Programmation en matière d’institutions de soins hospitaliers. Expertise internationale (Europe, Afrique, Asie, Amérique latine).
1.10 Fondateur et Gérante de la Société« VM-AN Consulting, snc » janvier 2013
1.11 Conseillère communale suppléante, Lasne, Belgique, depuis octobre 2018.
2020-06-10_CvULB.docx Page 2/29
Titres universitaires.
Université Libre de Bruxelles
1. Licence en Sciences Physiques (1968) Grade : Distinction.
Mémoire en Physique Nucléaire, titre : "Interaction Coulombienne de deux Oscillateurs harmoniques". Juillet 1968.
2. Agrégation de l'Enseignement Secondaire Supérieur (1968) Grade : Distinction
3. Licence Spéciale en Radiobiologie (1973) Grade : La plus grande distinction
4. Doctorat en Sciences (pour le groupe des Sciences Physiques) (1978) Grade : La plus grande distinction
Thèse de doctorat; titre : “ Etude théorique des propriétés cinétiques de la phase G1 du cycle mitotique ”
5. Cours de spécialisation à l’Institut de Statistique, dans le cadre de la Licence spéciale en Mathématiques appliquées à la Gestion. (1978-1979)
6. GCP Certificate of training (2011).
7. Formation SAS (2011)
8. Refresh GCP Certificate of training (2013).
II. Carrière scientifique :
3.1 Postes occupés
• Professeur émérite à l’ULB depuis octobre 2012.
• Professeur invitée à l’ULB depuis octobre 2017.
• Chargé de cours MS-MEDN- Master de spécialisation en médecine nucléaire – Partim statistique. Depuis 2001.
• Chef du Service de Biostatistique et Informatique Médicale, Fac. de Médecine, ULB, 2006- 2012.
• Professeur temps plein à l’ULB du 01.01.2003 au 30.09.2012 Professeur à l’ULB depuis 1996.
Chargé de cours à l'ULB de 1980 à 1996.
Chef de travaux à l'ULB de 1980 à 2003.
Chargé de conférence à l'ULB de 1979 à 1980.
1
erassistant à l'ULB de 1979 à 1980.
Suppléant à l'ULB de1978 à 1979.
Assistant à l'ULB de 1971 à 1979.
Chercheur à l'ULB (Lab. de Médecine Nucléaire, Fac. Médecine) de 1969 à 1971, contrat
ARC.
2020-06-10_CvULB.docx Page 3/29
• Consultant pour l’AFMPS (Agence Fédérale des Médicaments et produits de Santé) depuis avril 2010.
• Expert pour l’AFSCA (Agence Fédérale pour la Sécurité de la Chaîne Alimentaire) sporadiquement depuis 2006.
• Expert pour l’IRSIB (Institut d’encouragement de la Recherche Scientifique et de l’Innovation de Bruxelles) depuis 2005.
• Consultant auprès de l’EMEA (Agence Européenne pour l’Evaluation des Médicaments)- Londres depuis 2001.
• Consultant au Ministère des Affaires Sociales, de la Santé Publique et de l’Environnement – Inspection générale de la pharmacie depuis 2001.
• Conférencier à l'ULB pour le volet "Biostatistics"- partim- des cours Pharmed (3
ecycle maîtrise en pharmacologie et médecine appliquée à l'industrie pharmaceutique) depuis 1992.
• Attachée à la direction de l'hôpital Erasme pour les projets de consultance en programmation hospitalière depuis 1988.
• Conférencier et chairman dans le cadre du Certificat de Médecine factuelle (ULB ) depuis 2008
• Responsable principale du volet statistique d'un essai clinique de phase I et Phase II (Cydofovir) depuis 2009.
3.2 Séjours à l'étranger
- Stage de recherche de 3 mois au Centre de recherche de l'EURATOM à Ispra (Italie), octobre à
décembre 1968; boursier de l'Euratom (Communautés Européennes)
2020-06-10_CvULB.docx Page 4/29
IV. Carrière d’enseignement
4.1. Enseignement universitaire: ULB
4.1.1 Cours théoriques.
STAT-G-201-A- Statistiques appliquées aux sciences biomédicales – th 2ECTS- MED 2, BIMEL
STAT-G-201- Statistiques appliquées aux sciences biomédicales – th 2ECTS- ex 2 ECTS- DENT2
STAT-G-202- Statistiques– th 1 ECTS- T pers 1 ECTS- BIME2 STAT-G-203 Biostatistique– th 1 ECTS- - TP 1 ECTS- VETE2
INFO-G-500 - Utilisation des outils informatiques pour l’analyse de données biologiques – 1 ECTS – BIME5
STAT-I-301 – Eléments de Biostatistique – th 1,5 ECTS – ex 1 ECTS – EDPH 3 P, M, S, KINE3, MOTR3 E, O
MEMO-I-400 - Utilisation des outils informatiques pour l’analyse de données biologiques – 1 ECTS – EDPH4C, EDPH4D, EDPH4P, MOTR4T
STAT-J-201 – Biostatistique – th 1,5 ECTS – ex 1 ECTS – T. pers 0.5 ECTS – PHAR2
SAPU-L-903 – Méthodes statistiques appliquées aux études de santé au travail – th 2 ECTS – T. pers 4 ECTS - MTRA9
SAPU-L-660 – Demography – th 1 ECTS – T. pers 1 ECTS – STME6
CERTIFICAT MÉDECINE FACTUELLE (Fac de Médecine ULB) depuis 2008
PHARMED (post-graduate programme in pharmaceutical medicine/drug development sciences). Séminaires de Biostatistique. Depuis 1992
MASTER COMPLÉMENTAIRE en MEDECINE NUCLEAIRE
.Advanced statistics.
Depuis 1996.
.
Détails:
- Demography 2ECTS (th é orie 1, travaux personnels:1) (SAPU-L-660) Master
compl é mentaire (Master in Public Health Methodology) organis é conjointement par l'UMH et l'ESP-ULB, actuellement géré par l'UMH. Depuis avril 2009
- Utilisation des moyens informatiques d'analyse de données 1ECTS (exercices) (MEMO-I- 402). MOTR4 Depuis 2008-2009.
- Statistiques appliquées aux sciences biomédicales (STAT 088, actuellement STAT- G-201- 202-203), th.15h-TP 15h, depuis 1996. ((BA2) Médecine, Sc. Dentaire, Sc. Biomédicales, Sc.
Vétérinaires)
2020-06-10_CvULB.docx Page 5/29 - Méthodes statistiques appliquées aux études de santé au travail (STAT 085, devenu TRAV-L-
903), 6ECTS, depuis 1996 (DES en Médecine du travail)
- Eléments de statistique générale et appliquée (STAT 033, actuellement STAT-I-301) th.15h, TP 15h, depuis 1980. (Kiné3., Motr3)
- Biostatistique (STAT-J-201) th.15h, TP 15h, (Pharma2) depuis 1987.
- Utilisation des outils informatiques pour l’analyse statistique des données biologiques (INFO 094 devenu INFO-G-500) 1,5 crédits ECTS. (BIME3 depuis 2004). (BIME5 depuis
2008).
- Méthodes statistiques pour l'évaluation de l'efficacité diagnostique des méthodes
d’investigation, 15h (3
ecycle formation des spécialistes en médecine nucléaire), depuis 1986 - Participation aux collèges d’enseignement des DES en orthodontie, en parodontologie (depuis
1992).
- Bioinformatique et Biostatistique (th. 2 ECTS, Exercices 2ECTS) Partim 1/2. (1
eLic.
Biologie Moléculaire et Médicale- Orientation Biotechnologie) ULB-UMH, 2003-2004.
- Biostatistics (20 h): Post-graduate Program in Pharmacology and Pharmaceutical Medicine.
Programme PHARMED) depuis 1992.
- introduction mathématique et éléments de statistique (MATH, STAT) de 1978 à 1980 - statistique appliquée aux études cliniques et de laboratoire (STAT 038), th.20h, TP 20h, 1994-
1995
- statistiques démographiques et sanitaires (STAT 825) 25h, de 1983 à 1995
4.1.2 Travaux pratiques :
- exercices et séminaires de biostatistique, charge plein temps (330 heures/an) de 1971 à 1980
4.2. Enseignement non universitaire.
- Physique générale, 30h (Institut Supérieur de Kinésithérapie et Physiotechnique) de 1978 à 1985
- Mathématiques, Dessin technique, mi-temps de janvier 1989 à novembre 1969; Institut Meurisse-CERIA
4.3. Direction de travaux de fin de 2ème et 3ème cycles:
- Doctorat en Biostatistique de M. Pierre CULLUS depuis2008
- Postdoctorat de Mr Didier POTTIER –Dr en Sc. Biologiques- Université de Caen,
France.
2020-06-10_CvULB.docx Page 6/29 - Stage de perfectionnement en Statistique médicale du Dr. Mohamed SYLLA, chef du Service de Statistique à l’Inspection Régionale de la Santé de la Basse Guinée (01-10- 1988 au 30-09-1989).
- Mémoire en biostatistique de Mademoiselle Bénédicte DELCOIGNE : Licence Spéciale en Statistique (1995-1996).
- Mémoire en biostatistique de Mademoiselle Catherine LEGRAND - Licence en Sciences Mathématiques : Orientation Statistique (1997-1998). Titre : L’analyse discriminante : Théorie statistique et applications en médecine.
- Mémoire en biostatistique de Mademoiselle Florence MOTTE - Licence en Sciences Mathématiques : orientation Statistique (1998-1999). Titre : Méthodes de
bioéquivalence; comparaison des effets d'un antibiotique administré sous deux modalités différentes.
- Mémoire en biostatistique de Mademoiselle Cathy MICUS - Licence en Sciences Mathématiques : orientation Statistique (1998-1999). Titre : Application médicale de la régression logistique à des données recueillies lors d'une étude pneumologique.
V. Publications et activités scientifiques
5.1 Listes des publications
5.1.1 Ouvrages publiés en collaboration
DE MAERTELAER V.
Cell loss from germinative populations.
In : "Developments in Cell Biology, vol 2 - Biomathematics and Cell Kinetics", ed by AJ Valleron and PDM Mac Donald. Elsevier/North Holland Biomedical Press - Amsterdam - New York (1978) pp 103-113.
DE MAERTELAER V, HEENEN M, GALAND P.
A mathematical model for the evolution of a psoriatic lesion. in "Psoriasis : cell proliferation". Ed by NA Wright, RS Cample John.
Churchill Livingstone Edinburgh. London, Melbourne and New York, (1983) pp 300-305.
5.1.2 Articles dans des revues scientifiques internationales avec comité de lecture
1.DE MAERTELAER, V. CANTRAINE F.
Solutions and modeling for linear differential systems with constant coefficients.
Computer Programs in Biomedicine 2 (1971) 51-60.
2.KLASTERSKY J, SWINGS G, VANDENBORRE L, WEERTS D, DE MAERTELAER, V.
Effectiveness of the carbenicillin/cephalothin combination against Gram negative bacilli.
Amer J Med Sci 265, 1 (1973) 45-53.
3.KLASTERSKY J, DANEAU D, DE MAERTELAER V.
Comparative study of tobramycin and gentamicin with special reference to their anti-pseudomonas activity.
Clin Pharmacol Ther, 14 (1973) 104-111.
2020-06-10_CvULB.docx Page 7/29
4.SAND G, FRUHLING J, PLATTEN-GODFROID C.
Contribution à l'étude de l'ultrastructure de la corticosurrénale de cobaye. J. de Microscopie 17 (1973) 283-298.
Annexe : DE MAERTELAER, V : Méthode de calcul du volume de la surrénale de cobaye.
5.DE MAERTELAER V, GALAND P.
Cell kinetics : unpredicted behavior of a "Go " - model of the mitotic cycle.
IRCS 2 (1974) 1292.
6.DE MAERTELAER V, GALAND P.
Some properties of a "Go " - model of the cell cycle.
I. Investigation on the possible existence of natural constraints on the theoretical model in steady-state conditions.
Cell and Tissue Kinetics 8 (1975) 11-22.
7.BIANCHI C, CANTRAINE F, DE MAERTELAER V, COLI A, PALLA R, FABRINI GC.
Reappraisal of serum creatinine as an index of the glomerular filtration rate (measured by external counting).
The J of Nuclear Biology and Medicine 20 (1976) 126-131.
8.DE MAERTELAER V, GALAND P.
Some properties of "Go " - model of the cell cycle. II. Natural constraints on the theoretical model in exponential growth conditions.
Cell and Tissue Kinetics 10 (1977) 35-42.
9.DE MAERTELAER V, GALAND P.
Stimulated cell kinetics. Susceptibility for induced differentiation as a function of cell age. IRCS 5 (1977) 127.
10.DE MAERTELAER V, GALAND P.
Cell kinetics : a model of stimulated populations.
J Theoretical Biology 69 (1977) 429-445.
11.BLEIBERG H, ROZENCWEIG M, LONGEVAL E, FRUHLING J, DE MAERTELAER V.
Detection of liver metastases : usefulness of peritoneoscopy as complement of liver function tests and liver scintigraphy in 240 cases of cancer.
Surg Gynec Obst 145 (1977) 821 - 825.
12.DE MAERTELAER V.
Cell loss from germinative populations.
In : "Developments in Cell Biology, vol 2 - Biomathematics and Cell Kinetics", ed by AJ Valleron and PDM Mac Donald. Elsevier/North Holland Biomedical Press - Amsterdam - New York (1978) pp 103-113.
13.DE MAERTELAER V.
Heterogeneity of transit times in the G1-phase of the mitotic cycle during embryonic development . IRCS 6 (1978) 445.
14.HEENEN M, DE MARTELAER V, GALAND P.
Psoriasis and cell cycle, a computer simulation.
Acta Dermatovener (Stockholm) suppl 87 (1979) 73-76.
15.LEJEUNE B, DE MAERTELAER V, LEROY C, DELCROIX C.
Analysis of epithelial mitosis distribution along uterine horns in mice.
Cell and Tissue Kinetics 13 (1980) 201.
16.DORCHY H, MOZIN MJ, DE MAERTELAER V, TOUSSAINT D, LOEB H
Relations entre ingesta lipidiques (cholestérol, graisses saturées et polyinsaturées), cholestérolémie, contrôle métabolique (HbA ) et rétinopathie des enfants diabétiques.
La Revue de Pédiatrie 17 (1981) 259-269.
17.DE MAERTELAER V, AUTHELET M, NEVE P.
Effect of aging on the proliferative activity of renewing cell populations after a specific stimulus. IRCS Med Sci 9 (1981) 548-549.
18.DE MAERTELAER V, AUTHELET M, NEVE P.
Effect of aging on the proliferative activity of the vaginal epithelial germinative cells as a response to oestrogenic stimulation.
Cell Tissue Kinetics 15 (1982) 101.
19.DE MAERTELAER V, BRAMBILLA E, MENDELSOHN J, NAAKTGEBOREN J, BERNHEIM J.
Rate of DNA synthesis as a function of cell age DNA content from combined microspectrofluorometric and autoradiographic data.
Cell Tissue Kinetics 15 (1982) 101-102.
20.BROHEE D, RONDELEZ L, BAIN H, DE MAERTELAER V.
Kidney Ageing and Renal Excretion of Amylase.
Gerontology 28 (1982) 386-391.
21.SCHOLLER Y, DE MAERTELAER V, MALAISSE W J.
Mathematical modelling of stimulus secretion coupling in the pancreatic B cell. I. Dynamics of insulin release.
Acta Diabetologica Latina, 20 (1983) 329-340.
22.DE MAERTELAER V, POTTIER D.
Cell populations need an internal regulatory mechanism to recover their initial steady state after a transient hormone-like modulation.
IRCS Journal of Medical Science, 11 (1983) 871-873.
2020-06-10_CvULB.docx Page 8/29
23.SCHOLLER Y, DE MAERTELAER V, MALAISSE W J.
Mathematical modelling of stimulus-secretion coupling in the pancreatic ß-cell. III. Glucose-induced inhibition of calcium efflux.
Biophys J 46 (1984) 439-446.
24.POORTMANS J, DORCHY H, DE MAERTELAER V.
Subclinical Proteinuria in type I Diabetic Children and Adolescents : Relationship to Duration of Diabetes, Metabolic Control, HLA-DR Type, Retinopathy and Neuropathy.
Diabetic Nephropathy 3 (1984) 123-126.
25.DORCHY H, NOEL P, KRUGER M, DE MAERTELAER V, DUPONT E, TOUSSAINT D, PELC S.
Peroneal motor nerve conduction velocity in diabetic children and adolescents. Relationship to metabolic control, HLA-DR types, retinopathy and EEG.
Eur J Pediatrics 144 (1985) 310-315.
26.SCHOLLER Y, DE MAERTELAER V, MALAISSE W J.
Mathematical modelling of stimulus-secretion coupling in the pancreatic ß-cell. II. Calcium-stimulated calcium release.
Comput Programs Biomed 19 (1985) 119-126.
27.DE MAERTELAER V, POTTIER D.
Stability conditions of cell populations in vivo.
J Theor Biol 113 (1985) 299-310.
28.UNGER J, DE MAERTELAER V, GOLSTEIN J, DECOSTER C, JONCKHEER M H.
Relationship between serum thyrogobulin and intrathyroidal stable iodine in human simple goiter.
Clin Endocrinol 23 (1985) 1- 6.
29.DEVIERE J, KENNES B, CLOSSET J D, DE MAERTELAER V, NEVE P.
Immune senescence : effect of age, sex and health on human blood mononuclear subpopulations.
Arch Gerontol Geriatr 4 (1985) 285-293.
30.LINKOWSKI P, DE MAERTELAER V, MENDLEWICZ J.
Suicidal behaviour in major depressive illness.
Acta psychiat Scand 72 (1985) 233-238.
31.KERKHOFS M, HOFFMAN G, DE MAERTELAER V, LINKOWSKI P, MENDLEWICZ J.
Sleep EEG Recordings in Depressive Disorders.
J Affect Disorders 9 (1985) 47-53.
32.MALAISSE W J, SCHOLLER Y, DE MAERTELAER V.
Mathematical modelling of stimulus-secretion coupling in the pancreatic B-cell. IV. Dissociated time course for the glucose-induced changes in distinct Ca2+ movements.
Diabetes Res 2 (1985) 195-199.
33.BROHEE D, DE MAERTELAER V, PIRO P, KENNES B, NEVE P.
Specific Effect of Age on Lectin-Induced Mitogenesis of Lymphocytes from Diseased Patients. Gerontology 32 (1986) 74-80.
34.DORCHY H, NOEL P, KRUGER M, DE MAERTELAER V, DUPONT E, TOUSSAINT D, PELC S.
Peroneal Motor Nerve Conduction Velocity in Diabetic Children and adolescence. Relationships to Metabolic Control, HLA-DR Antigens, Retinopathy, and Electroencephalogram.
Pediatr Adolesc Endocrinol 15 (1986) 252-261.
35.DORCHY H, POORTMANS J, DE MAERTELAER V.
Protéinurie subclinique chez les enfants et les adolescents diabétiques. Absence de relation avec les antigènes HLA-DR, la rétinopathie et la neuropathie débutantes.
Diabète et Métabolisme 12 (1986) 97.
36.KENNES B, DEVIERE J, BROHEE D, DE MAERTELAER V, NEVE P.
The effect of age, sex and health status on the distribution and functions of human blood mononuclear subpopulations.
Modern trends in ageing research 147 (1986) 231-234.
37.LINKOWSKI P, CASTRO P, DE MAERTELAER V, MENDLEWICZ J.
TSH Response to TRH : a multivariate study.
Biol Psychiatry 7 (1986) 767-769.
38.BROHEE D, DE MAERTELAER V, PIRO P, KENNES B, NEVE P.
Age -specific effect on lectin-mitogenesis by lymphocytes from diseased patients.
Cytobios 45 (1986) 139-146.
39.MEUNIER-CARPENTIER F, VAN DER AUWERA P, SCHMITT H, DE MAERTELAER V, KLASTERSLY J.
Pharmacokinetic of gentamicin after IV infusion or IV bolus.
J Antimicrobial Chemotherapy 19 (1987) 225-231.
40.JEANTY P, COUSSAERT E, DE MAERTELAER V, CANTRAINE F.
Sonographic detection of smoking-related decreased fetal growth.
J. Ultrasound Med 6 (1987) 13-19.
2020-06-10_CvULB.docx Page 9/29
41.DE MAERTELAER V, JACQUY J.
Multivariate analysis of the effect of climatic factors on the probability of cerebral infarction according to age.
Acta Neurol Scand 75 (1987) 56-61.
42.DE MAERTELAER V, CALAY R, NEVE P.
Thyroid, Lipid and Other Biological Variables in Elderly Patients with Asymptomatic Autoimmune Thyroiditis : A Statistical Analysis.
Gerontology 33 (1987) 315-326.
43.FERY F, DE MAERTELAER V, BALASSE E O.
Mechanism of the hyperketonaemic effect of prolonged exercice in insulin - deprived Type 1 (insulin - dependent) diabetic patients.
Diabetologia 30 (1987) 298-304.
44.DE MAERTELAER V, HOFFMAN G, LEMAIRE M, MENDLEWICZ J.
Sleep Spindle Activity Changes in Patients With Affective Disorders.
Sleep 10 (1987) 443-451.
45.DEVIERE J, BROHEE D, KENNES B, DE MAERTELAER V, NEVE P,
Effect of age, sex and health state on human lymphocyte functions : demonstration of a sex-related defect in suppressor cell function.
Arch Gerontol Geriatr 6 (1987) 163-175.
46.HEENEN M, GALAND P, DE MAERTELAER V, HEENEN PH
Psoriasis: hyperproliferation cannot induce characteristic epidermal morphology.
Cell Tissue Kinet 20 (1987) 561-570.
47.KERKHOFS M, KEMPENAERS C, LINKOWSKI P, DE MAERTELAER V, MENDLEWICZ J, Multivariate study of sleep EEG in depression.
Acta Psychiatr Scand 77 (1988) 463-468.
48.LINKOWSKI P, DE MAERTELAER V, DELARBRE C, PAPADIMITRIOU G, MENDLEWICZ J.
Familial factors in suicidal behavior.
Int J Family Psychiatry. (Int Universities Press, Inc, Madison, CT) 9 (1989) 123-133.
49.DORCHY H, DE SCHEPPER J, HAENTJENS M, DE MAERTELAER V, VEROUGSTRAETE C, LOEB H
The course of incipient diapetic retinopathy in youth as revealed by fluorescein angiography.
Pediatr Adolesc Endocrinol 18 (1989) 101-106.
50.GILLES C, RYCKAERT P, DE MOL J, DE MAERTELAERE V, MENDLEWICZ, J.
Clonidine-induced growth hormone secretion in elderly. Patients with senile dementia of the Alzheimer type and major depressive disorder.
Psychiatry Res 27 (1989) 277-286.
51.MENDLEWICZ J, SEVY S, DE MAERTELAER V.
REM Sleep Latency and Morbidity Risk of Affective Disorders in Depressive Illness.
Neuropsychobiology 22 (1989) 14-17.
52.MENDLEWICZ J, HIRSCH D, SEVY S, SURMONT D, PAPADIMITRIOU G, DE MAERTELAER V.
Alpha-2-Adrenoreceptor binding as a possible vulnerability marker for affective disorders.
Neuropsychobiology 22 (1989) 61-67.
53.DE MAERTELAER V, AUTHELET M, NEVE P.
Age-related cell cycle kinetics in the stimulated mouse vaginal epithelium.
Mech Age Dev 51 (1990) 73-80.
54.DELVENNE V, DELECLUSE F, HUBAIN Ph, SCHOUTENS A, DE MAERTELAER V, MENDLEWICZ J.
Regional cerebral blood flow in patients with affective disorders.
Brit J Psychiatry 157 (1990) 359-365.
55.HUBAIN PP, CASTRO P, MESTERS P, DE MAERTELAER V, MENDLEWICZ J.
Alprazolam and amitriptyline in the treatment of major depressive disorder : a double-blind clinical and sleep EEG study.
J Affect Disorders 18 (1990) 67-73.
56.KERKHOFS M, RIELAERT C, DE MAERTELAER V, LINKOWSKI P, CZARKA M, MENDLEWICZ J.
Fluoxetine in major depression : efficacy, safety and effects on sleep polygraphic variables.
Int Clin Psychopharmacology 4 (1990) 253-260.
57.SCHOUTENS A, LAURENT E, MARKOWICZ E, LISART J, DE MAERTELAER V.
Serum triidothyronine, bone turnover, and bone mass changes in euthuroid pre- and postmenopausal women.
Calcified Tissue Int 49 (1991) 95-100.
58.APPELBOOM T, DE MAERTELAER V, DE PREZ E, HAUZEUR J-P, DESCHODT-LANCKMAN M.
Enkephalinase : a physiologic neuroimmunomodulator detected in the synovial fluid.
Arthritis Rheum (1991) 1048-1051.
59.MENDLEWICZ J, KEMPENAERS C, DE MAERTELAER V.
2020-06-10_CvULB.docx Page 10/29
Sleep EEG and Amitryptiline Treatment in Depressed Inpatients.
Biol Psychiatry 30 (1991) 691-702.
60.DEMEESTER-MIRKINE N, HOOGHE L, VAN GEERTRUYDEN J, DE MAERTELAER V.
Hypocalcemia after thyroidectomy.
Arch Surg 127 (1992) 854-858.
61.DONNER C, DE MAERTELAER V, RODESCH F.
Multifetal pregnancy reduction : comparison of obstetrical results with spontaneous twin gestation. Eur J Obstet Gynecol Reprod Biol 44 (1992) 181-184.
62.CARLIER Y, RIVERA MT,TRUYENS C, ONTIVERO M, FLAMENT J, VAN MARCK E, DE MAERTELAER V.
Chaga's disease : decreased resistance to Trypanosoma Cruzi acquired infection in offspring of infected mice.
Am J Trop Med Hyg 46 (1992) 116-122.
63.LINKOWSKI P, MARTIN F, DE MAERTELAER V.
Effect of some climatic factors on violent and non-violent suicides in Belgium.
J Affect Disorders 25 (1992) 161-166.
64.GALAND P, DE MAERTELAER V.
Models of Oestrogen Action : A Cell Kineticist's View.
Epith Cell Biol 1 (1992) 177-188.
65.HAUZER JP, SINTZOFF S, APPELBOOM T, DE MAERTELAER V, BENTIN J, PASTEELS J L.
Relationship between magnetic resonance imaging and histologic findings by bone biopsy in nontraumatic osteonecrosis of the femoral head.
J Rheumatol 19 (1992) 385-92.
66 Biver F, Delvenne V, Goldman S, Luxen A, De Maertelaer V, Lotstra F, Mendlewicz J.
No hypofrontality in schizophrenia demonstrated by positron emission tomography Acta Psychiatr Belg. 1992 Sep-Oct;92(5):261-78
66.KEMPENAERS CH, SIMENON G, VANDER ELST M, FRANSOLET L, MINGARD P, DE MAERTELAER V, APPELBOOM TH, MENDLEWICZ J.
Effect of an Antidiencephalon immune serum on pain and sleep in primary fibromyalgia.
Neuropsychobiology 30 (1994) 66-72.
67.BIVER F, GOLDMAN S, DELVENNE V, LUXEN A, DE MAERTELAER V, HUBAIN P, MENDLEWICZ J, LOTSTRA F Frontal and Parietal Metabolic Disturbances in Unipolar Depression.
Biol Psychiatry 36 (1994) 381-388.
68.DELVENNE V, LOTSTRA F, GOLDMAN S, BIVER F, DE MAERTELAER V, APPELBOOM-FONDU J, SCHOUTENS A, BIDAUT L- M, LUXEN A, MENDLEWICZ J
Brain Hypometabolism of Glucose in Anorexia Nervosa : A pet Scan Study.
Biol Psychiatry 37 (1995) 161-169.
69.DONNER C, VERMEYLEN D, KIRPATRICK C, DE MAERTELAER V, RODESCH F
Management of the Growth-Restricted Fetus : The Role of Noninvasive tests and Fetal Blood Sampling.
Obstet Gynecol 85 (1995) 965-970.
70.GEVENOIS P A, ZANEN J, DE MAERTELAER V, DE VUYST P, DUMORTIER P, YERNAULT J-C.
Macroscopic assessment of pulmonary emphysema by image analysis.
J Clin Pathol 48 (1995) 318-322.
71.BIVER F, GOLDMAN S, LUXEN a, DELVENNE, V, DE MAERTELAER V, DE LA FUENTE J, MENDLEWICZ J, LOTSTRA F.
Altered frontostriatal relationship in unmedicated schizophrenic patients.
Psychiatry Res (Neuroimaging) 61 (1995) 161-171.
72.GEVENOIS P A, DE MAERTELAER V, DE VUYST P, ZANEN J, YERNAULT J-C Comparison of computed density and macroscopic morphometry in pulmonory emphysema.
Am J Respir Crit Care Med (formely Am Rev Respir Dis) 152 (1995) 653-657.
73.NOSEDA A, SCHMERBER J, PRIGOGINE T, DE MAERTELAER V, YERNAULT J-C Perception of dispnoea during acute changes in lung function in patients with either astma or COPD Respiratory Medicine 89 (1995) 477-485.
74.AVNI E F, CASSART M, DE MAERTELAER V, RYPENS F, VERMEYLEN D, GEVENOIS P A.
Sonographic prediction of chronic lung disease in the premature undergoing mechanical ventilation.
Pediatric Radiol 26 (1996) 463-469.
75.BIVER F, GOLDMAN S, DE MAERTELAER V, LUXEN A, MENDLEWICZ J, LOTSTRA F.
Interregional correlation of cerebral glucose metabolism in unmedicated schizophrenia.
Eur. Neuropsycho 6 (1996) 141-147.
76.DELBAERE A, BERGMANN P J M, GERVY-DECOSTER C, DESCHODT-LANCKMAN M, DE MAERTELAER V, ENGLERT Y Periovulatory elevation of Angiotensine II in the peritoneal fluid during the human menstrual cycle.
2020-06-10_CvULB.docx Page 11/29
J Clin Endocrinol Metab. 81 (1996) 2810-2815.
77.DELVENNE V, GOLDMAN S, DE MAERTELAER V, SIMON Y, LUXEN A, LOTSTRA F.
Brain hypometabolism of glucose in Anorexia Nervosa : normalization after weight gain.
Biol Psychiatry 40 (1996) 761-768.
78.GEVENOIS P A, DE VUYST P, DE MAERTELAER V, ZANEN J, JACOBOVITZ D, COSIO MG, YERNAULT J-C.
Comparison of computed density and microscopic morphometry in pulmonary emphysema Am J Respir Crit Care Med (formely Am Rev Respir Dis) 154 (1996) 187-192.
79.MARQUES DE ARAUJO S, RIVERA M T, EL BOUHDIDI A, DE MAERTELAER V, CARLIER Y.
Maternal Trypanosoma Cruzi Specific antibodies and worsening of acute infection in mice offspring.
Am J Trop Med Hyg 54 (1996) 13-17.
80.GEVENOIS P A, SCILLIA P, DE MAERTELAER V, MICHILS A, DE VUYST P, YERNAULT J-C The effects of age, sex, lung size and hyperinflation on CT lung densitometry
Am J Roentgenology 167 (1996) 1169-1173.
81.GEVENOIS P A, DE VUYST P, SY M, SCILLIA P, CHAMINADE L, DE MAERTELAER V, ZANEN J, YERNAULT J-C Pulmonary emphysema : quantitative CT during expiration.
Radiology 199 (1996) 825-829.
82.SOUERY D, LIPP O, MAHIEU B, MENDELBAUM K, DE BRUYN A, DE MAERTELAER V, VAN BROECKHOVEN C, MENDLEWICZ J
Excess Tyrosine hydroxylase restriction Fragment Length polymorphism Homozygosity in Unipolar but not bipolar patients : a preliminary report.
Biol Psychiatry 40 (1996) 305-308.
83.SOUERY D, LIPP O, MAHIEU B, MENDELBAUM K, DE MARTELAER V, VAN BROECKHOVEN C, MENDLEWICZ J Association study of bipolar disorder with Candidate Genes involved in Catecholamine
Neurotransmission : DRD2, DRD3, DAT1 and TH Genes Amer J of Med Genet (Neuropsych Genetics) 67 (1996) 551-556.
84.MAHIEU B, SOUERY D, LIPP O, MENDELBAUM K, VERHEYEN G, DE MAERTELAER V, VAN BROECKHOVEN C, MENDLEWICZ J
No association between bipolar affective disorder and a serotonin receptor (5-HT2A) polymorphism.
Psychiatry Res 70 (1997) 65-69.
85.LIESNARD C, DELFORGE M-L, TCHETCHEROFF M, DE MAERTELAER V, FARBER C-M, VANVOOREN J-P
Importance of method in the determination of syncytium - inducing phenotype of human immunodeficiency virus type 1 clinical isolates J Virol Methods 64 (1997) 137-145.
86.DE MAERTELAER V
Méta-analyse dans les essais cliniques.
Best of Respiratory 16 (1997) 3-5.
87.NOSEDA A, CARPIAUX J-P, MARKSTEIN C, MEYVAERT A, DE MAERTELAER V.
Disabling dyspnoea in patients with advanced disease : lack of effect of nebulized morphine.
Eur Respir J 10 (1997) 1079-1083.
88.DELVENNE V, GOLDMAN S, SIMON Y, DE MAERTELAER V, LUXEN A, LOTSTRA F.
Brain hypometabolism of glucose in bulimia nervosa.
Int J Eat Disord 21 (1997) 313-320.
89.DELBAERE A, BERGMANN PJM, GERVY-DECOSTER C, DESCHODT-LANCKMAN M, DE MAERTELAER V, STAROUKINE M, CAMUS M, ENGLERT Y.
Increased angiotensin II in ascites during severe ovarian hyperstimulation syndrome : role of early pregnancy and ovarian gonadotrophin stimulation.
Fertil Steril 67 (1997) 1038-1045.
90.DELVENNE V, GOLDMAN S, DE MAERTELAER V, WLIKER D, DAMHAUT P, LOTSTRA F.
Brain-glucose metabolism in anorexia nervosa and affective disorders: influence of weight loss or depressive symptomatology.
Psychiatry Research : Neuroimaging Section 74 (1997) 83-92.
91.DELBAERE A, BERGMANN PJM, GERVY-DECOSTER C, DE MAERTELAER V, CAMUS M, ENGLERT Y.
Prorenin and active renin levels in plasma and ascites during severe ovarian hyperstimulation syndrome.
Human Reprod 12 (1997) 236-240.
92.SOUERY D, LIPP O, SERRETI A, MAHIEU B, RIVELLI SK, CAVALLINI C, ACKENHEIL M, ADOLFSSON R, ASCHAUER H, BLACKWOOD D, DAM H, DELCOIGNE B, DE MAERTELAER V, DIKEOS D, FUCHSHUBER S, HEIDEN M, JABLENSKY A, JAKOVLJEVIC M, KESSING L, LERER B, MACEDO A, MELLERUP T, MILANOVA V, MUIR W, MENDLEWICZ J et al.
European collaborative project on affective disorders: interactions between genetic and psychosocial vulnerability factors.
Psychiatr Genet 8 (1998) 197-205.
93.GEVENOIS PA, DE MAERTELAER V, MADANI A, WINANT C, SERGENT G, DE VUYST P.
Asbestosis, pleural plaques and diffuse pleural thickening : three distinct benign responses to asbestos exposure.
2020-06-10_CvULB.docx Page 12/29
Eur Resp J 11 (1998) 1021-1027.
94.GLINEUR R, VAN SINT JAN S, LOURYAN S, PHILIPPSON C, DE MAERTELAER V, EVRARD L, ROOZE M.
Effects of Irradiation and Methyl-Triazene on Craniofacial Development in Mouse Embryos : A Semiautomated Morphometric Analysis Cleft - Palate craniofacial J 35 (1998) 342-350.
95.DUMORTIER P, COPLU L, DE MAERTELAER V, EMRI S, BARIS I, DE VUYST P.
Assessment of Environmental Asbestos Exposure in Turkey by Bronchoalveolar lavage.
Am J Respir Crit Med 158 (1998) 1815-1824.
96.GEVENOIS PA, SERGENT G, DE MAERTELAER V, GOUAT F, YERNAULT J-C, DE VUYST P.
Micronodules and emphysema in coal mine dust or silica exposure : relation with lung function.
Eur Resp J 12 (1998) 1020-1024.
97.DELFORGE ML, FARINE S, LIESNARD C, GULBIS B, DE MAERTELAER V, CLUMECK N, FARBER CM, VAN VOOREN JP Nutritional status and antiprotease therapy. Letter to the editor.
J of Acquired Imm Deficiency Syndromes and Human Retrovirology 18 (1998) 393-394.
98.DELVENNE V, GOLDMAN S, DE MAERTELAER V, LOTSTRA F
Brain-glucose metabolism in eating disorders assessed by positron emission tomography.
Int J Eat Disord 25 (1999) 29-37.
99.BANKIER AA, FLEISCHMANN D, DE MAERTELAER V, KONTRUS M, ZONTSICH T, HITTMAIRK, MALLEK R Subjective differentiation of normal and pathological bronchi on thin-section CT: impact of observer training.
Eur Resp J 13 (1999) 781-786.
100.BANKIER A, DE MAERTELAER V, KEYZER C, GEVENOIS PA
Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry.
Radiology 211 (1999) 851-858.
101.DEVREKER F, POGONICI E, DE MAERTELAER V, REVELARD P, VAN den BERGH M, ENGLERT Y Selection of good embryos for transfer depends on embryo size: implications for the "mild ovarian stimulation" debate.
Human Reprod 14 (1999) 3002-3008.
102.DAENS S, PERETZ A, DE MAERTELAER V, MORIS M, BERGMANN P
Efficiency of quantitative ultrasound measurements as compared with dualenergy X-ray aborptiometry in the assessment of corticosteroid- induced bone impairment.
Osteoporos Int 10 (1999) 278-283.
103.HAUZEUR JP, MATHY L, DE MAERTELAER V
Comparison between clinical evaluation and ultrasonography in detecting hydrarthrosis of the knee.
J Rheumatol 12 (1999) 2681-2683.
104.PERETZ A, DE MAERTELAER V, MORIS M, WOUTERS M, BERGMANN P
Evaluation of quantitative ultrasound and dual X-ray absorptiometry measurements in women with and without fractures.
J Clin Densitom 2 (1999) 127-133.
105.GALLE C, DE MAERTELAER V, MOTTE S, ZHOU L, STORDEUR P, DELVILLE JP, LI R, FERREIRA J, GOLDMAN M, CAPEL P, WAUTRECHT JC, PRADIER O, DEREUME JP.
Early inflammatory response after elective abdominal aortic aneurysm repair: a comparison between endovascular procedure and conventional surgery.
J Vasc Surg. 2000 Aug;32(2):234-46.
106.PERETZ A, PENALOZA A, MESQUITA M, DRATWA M, VERHAS M, MARTIN P, DE MAERTELAER V, BERGMANN P.
Quantitative ultrasound and dual X-ray absorptiometry measurements of the calcaneus in patients on maintenance hemodialysis.
Bone. 2000 Aug;27(2):287-92.
107.NOSEDA A, DE BRUYNE I, DE MAERTELAER V, YERNAULT JC.
Does an IV bolus of methylprednisolone relieve dyspnea in asthma exacerbations?
Chest. 2000 Dec;118(6):1530-7.
2001
108.MATHIEU F, SUETENS C, BEGAUX F, DE MAERTELAER V, HINSENKAMP M.
Effects of physical therapy on patients with Kashin-Beck disease in Tibet.
Int Orthop. 2001;25(3):191-3.
109.HINSENKAMP M, RYPPENS F, BEGAUX F, MATHIEU F, DE MAERTELAER V, LEPEIRE M, HAUBRUGE E, CHASSEUR C, STALLENBERG B.
The anatomical distribution of radiological abnormalities in Kashin-Beck disease in Tibet.
Int Orthop. 2001;25(3):142-6.
110.MATHIEU F, BEGAUX F, SUETENS C, DE MAERTELAER V, HINSENKAMP M.
Anthropometry and clinical features of Kashin-Beck disease in central Tibet.
2020-06-10_CvULB.docx Page 13/29
Int Orthop. 2001;25(3):138-41.
111.MICHILS A, REDIVO M, ZEGERS DE BEYL V, DE MAERTELAER V, JACOBOVITZ D, ROCMANS P, DUCHATEAU J.
Increased expression of high but not low molecular weight heat shock proteins in resectable lung carcinoma.
Lung Cancer. 2001 Jul;33(1):59-67.
112.STALLENBERG B, ROMMENS J, LEGRAND C, DE MAERTELAER V, METENS T, GEVENOIS P A.
Radiographic diagnosis of rotator cuff tear based on the supraspinatus muscle radiodensity.
Skeletal Radiol. 2001 Jan;30(1):31-8.
113.DUMORTIER P, COPLU L, BROUCKE I, EMRI S, SELCUK T, DE MAERTELAER V, DE VUYST P, BARIS I.
Erionite bodies and fibres in bronchoalveolar lavage fluid (BALF) of residents from Tuzkoy, Cappadocia, Turkey.
Occup Environ Med. 2001 Apr;58(4):261-6.
114.DE MAERTELAER V, LE MOINE O, DEVIERE J.
Letter to the Editor
Gastroenterology 2001; 121(1):233
2002
115. DEVIERE J, PASTORELLI A, LOUIS H, DE MAERTELAER V, LEHMAN G, CICALA M, LE MOINE O, SILVERMAN D, COSTAMAGNA G.
Endoscopic implantation of a biopolymer in the lower esophageal sphincter for gastroesophageal reflux: A pilot study. Gastrointest Endosc. 2002 Mar;55(3):335-341.
116.MICHILS A, DUTRY D, DE BEYL VZ, REMMELINK M, DE MAERTELAER V, ROCMANS P.
Peripheral Blood Mononuclear Cell Proliferation to Heat Shock Protein-70 Derived from Autologous Lung Carcinoma.
Am J Respir Crit Care Med. 2002 Sep;166(5):749-753.
117.AVNI FE, SEGERS V, DE MAERTELAER V, CADRANEL S, DASSONVILLE M, DELAET MH, NICAISE N, METENS T.
The evaluation by magnetic resonance imaging of hepatic periportal fibrosis in infants with neonatal cholestasis: preliminary report.
J Pediatr Surg. 2002 Aug;37(8):1128-33.
118.AVNI FE,GUISSARD G,HALL M,JANSSEN F,DEMAERTELAER V,RYPENS F.
Hereditary polycystic kidney diseases in children: changing sonographic patterns through childhood.
Pediatr Radiol. 2002 Mar;32(3):169-74.
119.TEITELBAUM V, BALON-PERIN A, DE MAERTELAER V, DAELEMANS P, GLINEUR R.
Impact of dental and skeletal movements on the facial profile within the framework of orthodontic and surgical treatments.
Int J Adult Orthodon Orthognath Surg. 2002;17(2):82-8.
120.CHRISTOPHE C, FONTEYNE C, ZIEREISEN F, CHRISTIAENS F, DELTENRE P, DE MAERTELAER V, DAN B.
Value of MR imaging of the brain in children with hypoxic coma.
AJNR Am J Neuroradiol. 2002 Apr;23(4):716-23.
121.NOSEDA A, NOUVELLE M, LANQUART JR, KEMPENAERS CH, DE MAERTELAER V, LINKOWSKI R, KERKHOFS M.
High leg motor activity in sleep apnea hypopnea patients: efficacy of clonazepam combined with nasal CPAP on polysomnographic variables.
Respir Med. 2002 Sep;96(9):693-9.
2003
122.MEWASINGH LD, CHRISTOPHE C, FONTEYNE C, DACHY B, ZIEREISEN F, CHRISTIAENS F, DELTENRE P, DE MAERTELAER V, DAN B.
Predictive value of electrophysiology in children with hypoxic coma.
Pediatr Neurol. 2003 Mar;28(3):178-83.
123.BOON N, DELHAYE M, LE MOINE O, DE MAERTELAER V, DEVIERE J.
Severity of acute gallstone pancreatitis in patients with pancreas divisum.
Endoscopy. 2003 May;35(5):407-10.
124.TACK D, SOURTZIS S, DELPIERRE I, DE MAERTELAER V, GEVENOIS PA.
Low-dose unenhanced multidetector CT of patients with suspected renal colic.
AJR Am J Roentgenol. 2003 Feb;180(2):305-11.
125.DUMORTIER P, THIMPONT J, DE MAERTELAER V, DE VUYST P.
Trends in asbestos body counts in bronchoalveolar lavage fluid over two decades.
Eur Respir J. 2003 Sep;22(3):519-24.
126.TACK D,WIDELEC J,DE MAERTELAER V,BAILLY JM,DELCOUR C,GEVENOIS PA.
Comparison between low-dose and standard-dose multidetector CT in patients with suspected chronic sinusitis.
AJR Am J Roentgenol. 2003 Oct;181(4):939-44.
2020-06-10_CvULB.docx Page 14/29
127.TACK D,DE MAERTELAER V,GEVENOIS PA.
Dose reduction in multidetector CT using attenuation-based online tube current modulation.
AJR Am J Roentgenol. 2003 Aug;181(2):331-4.
128.ABADA HT, SAPOVAL MR, PAUL JF, DE MAERTELAER V, MOUSSEAUX E, GAUX JC.
Aneurysmal sizing after endovascular repair in patients with abdominal aortic aneurysm: interobserver variability of various measurement protocols and its clinical relevance.
Eur Radiol. 2003 Dec;13(12):2699-704. .
129.BANKIER AA, VAN MUYLEM A, SCILLIA P, DE MAERTELAER V, ESTENNE M, GEVENOIS PA.
Air trapping in heart-lung transplant recipients: variability of anatomic distribution and extent at sequential expiratory thin-section CT.
Radiology. 2003 Dec;229(3):737-42.
2004
130.ARVANITAKIS M, DELHAYE M, DE MAERTELAERE V, BALI M, WINANT C, COPPENS E, JEANMART J, ZALCMAN M, VAN GANSBEKE D, DEVIERE J, MATOS C.
Computed tomography and magnetic resonance imaging in the assessment of acute pancreatitis.
Gastroenterology. 2004 Mar;126(3):715-23.
131.ARVANITAKIS M, VAN LAETHEM JL, PARMA J, DE MAERTELAER V, DELHAYE M, DEVIERE J.
Predictive factors for pancreatic cancer in patients with chronic pancreatitis in association with K-ras gene mutation.
Endoscopy. 2004 Jun;36(6):535-42.
132.GANGJI V, HAUZEUR JP, MATOS C, DE MAERTELAER V, TOUNGOUZ M, LAMBERMONT M.
Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study.
J Bone Joint Surg Am. 2004 Jun;86-A(6):1153-60.
133.KEYZER C, TACK D, DE MAERTELAER V, BOHY P, GEVENOIS PA, VAN GANSBEKE D.
Acute appendicitis: comparison of low-dose and standard-dose unenhanced multi-detector row CT.
Radiology. 2004 Jul;232(1):164-72.
134.DAELEMANS C, SMITS G, DE MAERTELAER V, COSTAGLIOLA S, ENGLERT Y, VASSART G, DELBAERE A.
Prediction of Severity of Symptoms in Iatrogenic Ovarian Hyperstimulation Syndrome by Follicle-Stimulating Hormone Receptor Ser680Asn Polymorphism.
J Clin Endocrinol Metab. 2004 Dec;89(12):6310-5.
135.BANKIER AA, O'DONNELL CR, MAI VM, STOREY P, DE MAERTELAER V, EDELMAN RR, CHEN Q.
Impact of lung volume on MR signal intensity changes of the lung parenchyma.
J Magn Reson Imaging. 2004 Dec;20(6):961-6.
136.CORDONNIER M, DE MAERTELAER V.
Comparison between two hand-held autorefractors : the Sure-Sight and the Retinomax.
Strabismus. 2004 Dec;;12(4) 261-74.
2005
137.CORDONNIER M, DE MAERTELAER V.
Screening for Amblyogenic Factors in Preschool Children with the Retinomax Hand-Held Refractor:
Do Positive Children Have Amblyopia and Is Treatment Efficacious ? Strabismus. 2005 Jan; 13: 1-6.
138.CORBO M, DUJARDIN T, DE MAERTELAER V, MALEVEZ C, GLINEUR R.
Dentocraniofacial Morphology of 21 Patients With Unilateral Cleft Lip and Palate: A Cephalometric Study.
Cleft Palate Craniofac J. 2005 Nov;42(6):618-624.
139.TACK D, BOHY P, PERLOT I, DE MAERTELAER V, ALKEILANI O, SOURTZIS S, GEVENOIS PA.
Suspected acute colon diverticulitis: imaging with low-dose unenhanced multi-detector row CT.
Radiology. 2005 Oct;237(1):189-96. Epub 2005 Aug 26.
140.ARAKAWA H, GEVENOIS PA, SAITO Y, SHIDA H, DE MAERTELAER V, MORIKUBO H, FUJIOKA M.
Silicosis: expiratory thin-section CT assessment of airway obstruction.
Radiology. 2005 Sep;236(3):1059-66.
141.KEYZER C, ZALCMAN M, DE MAERTELAER V, COPPENS E, BALI MA, GEVENOIS PA, VAN GANSBEKE D.
Comparison of US and unenhanced multi-detector row CT in patients suspected of having acute appendicitis.
Radiology. 2005 Aug;236(2):527-34.
142. STAEBLER M, DONNER C, VAN REGEMORTER N, DUPREZ L, DE MAERTELAER V, DEVREKER F, AVNI F.
Should determination of the karyotype be systematic for all malformations detected by obstetrical ultrasound?
Prenat Diagn. 2005 Jul;25(7):567-73.
143. TACK D, DE MAERTELAER V, PETIT W, SCILLIA P, MULLER P, SUESS C, GEVENOIS PA.
2020-06-10_CvULB.docx Page 15/29
Multi-detector row CT pulmonary angiography: comparison of standard-dose and simulated low-dose techniques.
Radiology. 2005 Jul;236(1):318-25.
2006
144.MADANI A, ZANEN J, DE MAERTELAER V, GEVENOIS PA. Pulmonary emphysema:
objective quantification at multi-detector row CT--comparison with macroscopic and microscopic morphometry. Radiology. 2006 Mar;238(3):1036-43. Epub 2006 Jan 19.
145.RUBESOVA E, GRELL AS, DE MAERTELAER V, METENS T, CHAO SL, LEMORT M. Quantitative diffusion imaging in breast cancer: a clinical prospective study.
J Magn Reson Imaging. 2006 Aug;24(2):319-24.
146.ONCLINX C, DE MAERTELAER V, GUSTIN P, GEVENOIS PA.
Elastase-induced Pulmonary Emphysema in Rats: Comparison of Computed Density and Microscopic Morphometry.
Radiology. 2006 Dec;241(3):763-770.
147 HAINAUX B, AGNEESSENS E, BERTINOTTI R, DE MAERTELAER V, RUBESOVA E, CAPELLUTO E, MOSCHOPOULOS C.
Accuracy of MDCT in predicting site of gastrointestinal tract perforation. AJR Am J Roentgenol.
2006 Nov;187(5):1179-83.
148 DUMONCEAU JM, COSTAMAGNA G, TRINGALI A, VAHEDI K, DELHAYE M, HITTELET A, SPERA G, GIOSTRA E, MUTIGNANI M, DE MAERTELAER V, DEVIERE J.
Treatment for painful calcified chronic pancreatitis: extracorporeal shock wave lithotripsy versus endoscopic therapy. A randomised controlled trial.
Gut. 2006 Oct 17
2007
149.BANKIER AA, SCHAEFER-PROKOP C, DE MAERTELAER V, TACK D, JAKSCH P, KLEPETKO W, GEVENOIS PA.
Air Trapping: Comparison of Standard-Dose and Simulated Low-Dose Thin-Section CT Techniques. Radiology. 2007 Jan 23;
150. SIMONART T, DRAMAIX M, DE MAERTELAER V.
Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol. 2007 Nov 6; [Epub ahead of print]
PMID: 17986300 [PubMed - as supplied by publisher]
151.BOHY P, DE MAERTELAER V, ROQUIGNY A, KEYZER C, TACK D, GEVENOIS PA. Multidetector CT in patients suspected of having lumbar disk herniation:
comparison of standard-dose and simulated low-dose techniques. Radiology. 2007 Aug;244(2):524-31.
152. MADANI A, DE MAERTELAER V, ZANEN J, GEVENOIS PA.
Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification-- comparison with macroscopic and microscopic morphometry. Radiology. 2007 Apr;243(1):250-7.
153. ARVANITAKIS M, DELHAYE M, BALI MA, MATOS C, DE MAERTELAER V, LE MOINE O, DEVIERE J.
Pancreatic-fluid collections: a randomized controlled trial regarding stent removal after endoscopic transmural drainage. Gastrointest Endosc.
2007 Apr;65(4):609-19
154. BANKIER AA, SCHAEFER-PROKOP C, DE MAERTELAER V, TACK D, JAKSCH P, KLEPETKO W, GEVENOIS PA.
Air trapping: comparison of standard-dose and simulated low-dose thin-section CT techniques.
Radiology. 2007 Mar;242(3):898-906.
155.BOHY P, DE MAERTELAER V, ROQUIGNY A, KEYZER C, TACK D, GEVENOIS PA. Multidetector CT in patients suspected of having lumbar disk herniation:
comparison of standard-dose and simulated low-dose techniques. Radiology. 2007
Aug;244(2):524-31.
2020-06-10_CvULB.docx Page 16/29 156. MARÉCHAL R, DEMOLS A, GAY F, DE MAERTELAERE V, ARVANITAKI M, HENDLISZ A, VAN LAETHEM JL.
Prognostic factors and prognostic index for chemonaïve and gemcitabine-refractory patients with advanced pancreatic cancer.
Oncology. 2007;73(1-2):41-51. 2008 Mar 11.
157. SHAYEGAN A, DE MAERTELAER V, VANDEN ABBEELE A. The prevalence of traumatic dental injuries: a 24-month survey.
J Dent Child (Chic). 2007 Sep-Dec;74(3):194-9.
2008
158. SIMONART T, DRAMAIX M, DE MAERTELAER V .
Efficacy of tetracyclines in the treatment of acne vulgaris: a review. Br J Dermatol. 2008 Feb;158(2):208-16. Epub 2007 Nov 6. Review.
159. BALI MA, METENS T, DENOLIN V, DE MAERTELAER V , DEVIERE J, MATOS C. Pancreatic perfusion:
noninvasive quantitative assessment with dynamic
contrast-enhanced MR imaging without and with secretin stimulation in healthy volunteers--initial results.
Radiology. 2008 Apr;247(1):115-21. Epub 2008 Feb 21.
160. MARÉCHAL R, DEMOLS A, GAY F, DE MAERTELAER V , ARVANITAKI M, HENDLISZ A, VAN LAETHEM JL.
Tolerance and efficacy of gemcitabine and gemcitabine-based regimens in elderly patients with advanced pancreatic cancer.
Pancreas. 2008 Apr;36(3):e16-21.
161. LAMBOT T, VAN STEENBERGHE PR, VANMUYLDER N, DE MAERTELAER V, GLINEUR R. [Early treatment with rapid palatal expander and 3D Quad Action mandibular
appliance: evaluation of a comprehensive approach in 22 patients] Orthod Fr. 2008 Jun;79(2):107-14.
162.KEYZER C, PARGOV S, TACK D, CRÉTEUR V, BOHY P
, DE MAERTELAER V, GEVENOIS PA.Normal appendix in adults: reproducibility of detection with unenhanced and contrast-enhanced MDCT.
AJR Am J Roentgenol. 2008 Aug;191(2):507-14.
163.MADANI A, VAN MUYLEM A, DE MAERTELAER V , ZANEN J, GEVENOIS PA. Pulmonary emphysema:
size distribution of emphysematous spaces on multidetector CT images--comparison with macroscopic and microscopic morphometry.
Radiology. 2008 Sep;248(3):1036-41.
164.PASSANTE L, GASPARD N, DEGRAEVE M, FRISÉN J, KULLANDER K, DE MAERTELAER V, VANDERHAEGHEN P.
Temporal regulation of ephrin/Eph signalling is required for the spatial patterning of the mammalian striatum.
Development. 2008 Oct;135(19):3281-90.
1656 SIMONART T, DE MAERTELAER V.
Curettage treatment for molluscum contagiosum: a follow-up survey study. Br J Dermatol. 2008 Sep 15.
166.EHONGO A, DE MAERTELAER V, CULLUS P, POURJAVAN S.
Correlation between corneal hysteresis, corneal resistance factor, and ocular pulse amplitude in healthy subjects.
J Fr Ophtalmol. 2008 Dec;31(10):999-1005.
2009
167.EHONGO A, DE MAERTELAER V, POURJAVAN S.
Effect of topical corneal anaesthesia on ocular response analyzer parameters:
pilot study.
Int Ophthalmol. 2009 Oct;29(5):325-8
168.GANGJI V, ROOZE M, DE MAERTELAER V, HAUZEUR JP.
Inefficacy of the cementation of femoral head collapse in glucocorticoid-induced osteonecrosis.
2020-06-10_CvULB.docx Page 17/29 Int Orthop. 2009 Jun;33(3):639-42
169. GHAYE B, WILLEMS V, NCHIMI A, KOUOKAM L, NOUKOUA C, DE MAERTELAER V, GEVENOIS PA, Dondelinger RF.
Relationship between the extent of deep venous thrombosis and the extent of acute pulmonary embolism as assessed by CT angiography.
Br J Radiol. 2009 Mar;82(975):198-203.
170.NOSEDA A, ANDRÉ S, POTMANS V, KENTOS M, DE MAERTELAER V , HOFFMANN G. CPAP with algorithm- based versus titrated pressure: A randomized study.
Sleep Med. 2009 Oct;10(9):988-92
171. HINSENKAMP M, MATHIEU F, CLAUS W, COLLARD JF
, DE MAERTELAER V. Effects of physicalenvironment on the evolution of Kashin-Beck disease in Tibet.
Int Orthop. 2009 Aug;33(4):1085-8
172. DROSSOS K, REMMELINK M, NAGY N, DE MAERTELAER V, PASTEELS JL, SCHUIND F. Correlations Between Clinical Presentations of Adult Trigger Digits andHistologic Aspects of the A1
Pulley.
J Hand Surg Am. 2009 Aug 19.
173. FRANCISSE S, REVELARD P, DE MAERTELAER V, STREBELLE E, ENGLERT Y, LIESNARD C.
Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population.
Obstet Gynecol. 2009 Aug;114(2 Pt 1):285-91
174. ARVANITAKIS M, HOOKEY L, TESSIER G, DEMETTER P, NAGY N, STELLKE A, DE MAERTELAER V, DEVIÈRE J, LE MOINE O.
Intraductal optical coherence tomography during endoscopic retrograde cholangiopancreatography for investigation of biliary strictures.
Endoscopy. 2009 Aug;41(8):696-701.
175. CHAREZINSKI M, BALON-PERIN A, DEROUX E, DE MAERTELAER V, GLINEUR R. Transverse maxillary stability assisted by a transpalatal device: a retrospective pilot study of 9 cases.
Int J Oral Maxillofac Surg. 2009 Sep;38(9):937-41
176. FRANCISSE S, REVELARD P, DE MAERTELAER V, STREBELLE E, ENGLERT Y, LIESNARD C.
Human cytomegalovirus seroprevalence and risk of seroconversion in a fertility clinic population.
Obstet Gynecol. 2009 Aug;114(2 Pt 1):285-91.
177. DROSSOS K, REMMELINK M, NAGY N, DE MAERTELAER V , PASTEELS JL, SCHUIND F. Correlations between clinical presentations of adult trigger digits and histologic aspects of the A1
pulley.
J Hand Surg Am. 2009 Oct;34(8):1429-35. 2009 Aug 20.
178. KEYZER C, CULLUS P, TACK D, DE MAERTELAER V, BOHY P, GEVENOIS PA. MDCT for suspected acute appendicitis in adults: impact of oral and IV contrast media at standard-dose and simulated low-dose techniques.
AJR Am J Roentgenol. 2009 Nov;193(5):1272-81..
2010
179. SONG Y, MASSART C, CHICO-GALDO V, JIN L, DE MAERTELAER V, DECOSTER C, DUMONT JE, VAN SANDE J.
Mol Cell Endocrinol. 2010 May 5;319(1-2):56-62.
180. SIMONART T, DE MAERTELAER V.
Systemic Treatments for cutaneous warts : A systematic review. J Dermatolog Treat.
2012 Feb;23(1):72-7
2020-06-10_CvULB.docx Page 18/29
2011
181 . SIMONART T, KABAGABO C, DE MAERTELAER V.
Homoeopathic remedies in dermatology: a systematic review of controlled clinical trials. Br J Dermatol. 2011 Oct;165(4):897-905.
182. GANGJI V, DE MAERTELAER V , HAUZEUR JP.
Autologous bone marrow cell implantation in the treatment of non-traumatic osteonecrosis of the femoral head: Five year follow-up of a prospective controlled study.
Bone. 2011 Nov;49(5):1005-9
183. LIU Y, METENS T, ABSIL J, DE MAERTELAER V, BALERIAUX D, DAVID P, DENOLIN V, VAN OVERMEIRE B, AVNI F, VAN BOGAERT P, AEBY A.
Gender Differences in Language and Motor-Related Fibers in a Population of Healthy Preterm
Neonates at Term-Equivalent Age: A Diffusion Tensor and Probabilistic Tractography Study. AJNR Am J Neuroradiol. 2011 Dec;32(11):2011-6.
2012
184. LIU Y, AEBY A, BALÉRIAUX D, DAVID P, ABSIL J, DE MAERTELAER V , VAN BOGAERT P, AVNI F, METENS T White Matter Abnormalities Are Related to Microstructural Changes in Preterm Neonates at Term- Equivalent Age: A Diffusion Tensor Imaging and Probabilistic Tractography Study.
AJNR Am J Neuroradiol. 2012 May;33(5):839-45.
185. SIMONART T, de MAERTELAER V.
Systemic treatments for cutaneous warts: a systematic review. J Dermatolog Treat.
2012 Feb;23(1):72-7
2013
186. DEMEESTERE I, BRICE P, PECCATORI FA, KENTOS A, GAILLARD I, ZACHEE P,
CASASNOVAS RO, VAN DEN NESTE E, DECHENE J, DE MAERTELAER V , BRON D, ENGLERT Y.
Gonadotropin-Releasing Hormone Agonist for the Prevention of Chemotherapy-Induced Ovarian Failure in Patients With Lymphoma: 1-Year Follow-Up of a Prospective Randomized Trial J Clin Oncol. 2013 Mar 1;31(7):903-9.
187. BRASSART N, WINANT C, TACK D, GEVENOIS PA, DE MAERTELAER V, KEYZER C. Optimised z-axis coverage at multidetector-row CT in adults suspected of acute appendicitis.
Br J Radiol. 2013 Aug;86(1028):20130115.
2014
188. TACK D1, JAHNEN A, KOHLER S, HARPES N, DE MAERTELAER V, BACK C, GEVENOIS PA Multidetector CT radiation dose optimisation in adults: short- and long-term effects of a clinical audit.
Eur Radiol. 2014 Jan;24(1):169-75.
189. DEMEESTERE I, BRICE P, PECCATORI FA, KENTOS A, GAILLARD I, ZACHEE P, CASASNOVAS O, VAN DEN NESTE E, DECHENE J, DE MAERTELAER V, BRON D, ENGLERT Y.
Reply to Z. Blumenfeld et al.
J Clin Oncol. 2013 Oct 10;31(29):3722-3.
190. MICHALAKIS N, KEYZER C, DE MAERTELAER V, TACK D, GEVENOIS PA.
Reduced z-axis coverage in multidetector-row CT pulmonary angiography decreases radiation dose and diagnostic accuracy of alternative diseases.
Br J Radiol. 2014 Jan;87(1033):20130546.
191. KEYZER C, KNOOP C, VAN WETTERE M, DEHU M, GOSSET N, DE MAERTELAER V, GEVENOIS PA.
Cystic fibrosis: unenhanced CT description of the appendix in asymptomatic adults.
AJR Am J Roentgenol. 2014 Apr;202(4):759-64.
2020-06-10_CvULB.docx Page 19/29 192. MUTIJIMA E, DE MAERTELAER V, DEPREZ M, MALAISE M, HAUZEUR JP.
The apoptosis of osteoblasts and osteocytes in femoral head osteonecrosis: its specificity and its distribution.
Clin Rheumatol. 2014 Dec, (33) 1791-1795.
193. D'HONDT A, CORNIL A, BOHY P, DE MAERTELAER V, GEVENOIS PA, TACK D.
Tuning of automatic exposure control strength in lumbar spine CT.
Br J Radiol. 2014 May;87(1037):20130707
2015
194. MEDJEK M, HACKX M, GHAYE B, DE MAERTELAER V, GEVENOIS PA.
Value of the "spine sign" on lateral chest views
Br J Radiol. 2015 Jun;88(1050):20140378. doi: 10.1259/bjr.20140378. Epub 2015 Apr 1.
195. KEYZER C, DHAENE B, BLOCKLET D, DE MAERTELAER V, GOLDMAN S, GEVENOIS PA.
Colonoscopic Findings in Patients With Incidental Colonic Focal FDG Uptake.
AJR Am J Roentgenol. 2015 May;204(5):W586-91. doi: 10.2214/AJR.14.12817.
196. MICHAEL DERMIENCE, LOGNAY GEORGES, VIVIANE DE MAERTELAER, PHILIPPE MAESEN, JEAN-
MICHEL ROMNEE, FRANÇOISE MATHIEU, DENCHEN YANGZOM, TSEWANGThe relevance of food composition data for nutrition surveys in rural Tibet: pilot study in the context of Kashin-Beck Disease.
Biotechnologie, Agronomie, Société et Environnement ; 1370-6233 1780-4507
2016
197. HAUZEUR JP, MALAISE M, de MAERTELAER V.
A prospective cohort study of the clinical presentation of non-traumatic osteonecrosis of the femoral head: spine and knee symptoms as clinical presentation of hip osteonecrosis.
Int Orthop. 2016 Jan 5 Jan 5. [Epub ahead of print] PMID: 26728612
198. BROMBERG L, ROUFOSSE F, PRADIER O, DELPORTE C, VAN ANTWERPEN P, DE MAERTELAER V, COGAN E.
Methylprednisolone-induced lymphocytosis in patients with immune mediated inflammatory disorders.
Am J Med. 2016 Mar 8. S0002-9343(16)30201-7
199. ROOZE S, MATHIEU F, CLAUS W, YANGZOM T, YANGZOM D, GOYENS P, DE MAERTELAER V.
Effect of calcium and vitamin D on growth, rickets and Kashin-Beck disease in 0- to 5-year-old children in a rural area of central Tibet.
Trop Med Int Health. 2016 Jun;21(6):768-75. doi: 10.1111/tmi.12706. Epub 2016 May 24
200. DEMEESTERE I, BRICE P, PECCATORI FA, KENTOS A, DUPUIS J, ZACHEE P, CASASNOVAS O, VAN DEN NESTE E, DECHENE J, DE MAERTELAER V, BRON D, ENGLERT Y.
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial.
J Clin Oncol. 2016 Aug 1;34(22):2568-74. doi: 10.1200/JCO.2015.65.8864.
2017
201. FORTON FM, DE MAERTELAER V.
Two Consecutive Standardized Skin Surface Biopsies: An Improved Sampling Method to Evaluate Demodex Density as a Diagnostic Tool for Rosacea and Demodicosis.
Acta Derm Venereol. 2017 Feb 8;97(2):242-248. doi: 10.2340/00015555-2528
202. DEMEESTERE I, BRICE P, PECCATORI FA, KENTOS A, DUPUIS J, ZACHEE P, CASASNOVAS RO, VAN DEN NESTE E, DECHENE J, DE MAERTELAER V, BRON D, ENGLERT Y.
Reply to M. Lambertini et al.
2020-06-10_CvULB.docx Page 20/29 J Clin Oncol. 2017 Mar;35(7):805-806. doi: 10.1200/JCO.2016.70.6093. Epub 2016 Nov 28.
203. DERMIENCE M, MATHIEU F, LI XW, VANDEVIJVERE S, CLAUS W, DE MAERTELAER V, DUFOURNY G, BIN L, YANGZOM D, LOGNAY G.
Minerals and Trace Elements Intakes and Food Consumption Patterns of Young Children Living in Rural Areas of Tibet Autonomous Region, P.R. China: A Cross-Sectional Survey.
Healthcare (Basel). 2017 Mar 1;5(1). pii: E12. doi: 10.3390/healthcare5010012
2018
204. HAUZEUR JP, DE MAERTELAER V , BAUDOUX E, MALAISE M, BEGUIN Y, GANGJI V.
Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial.
Int Orthop. 2018 Jul;42(7):1429-1435. doi: 10.1007/s00264-017-3650-8. Epub 2017 Oct 7.
205. BOSSENS M, JOST M, VAN PACHTERBEKE C, DE MAERTELAER V, SIMON P, FRANKENNE F, HUBERT P, EVRARD B, SNOECK R.
Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation.
Int J Clin Pharmacol Ther. 2018 Mar;56(3):134-141.
206. FORTON FMN, DE MAERTELAER V.
Papulopustular rosacea and rosacea-like demodicosis: two phenotypes of the same disease?
J Eur Acad Dermatol Venereol. 2018 Jun;32(6):1011-1016
207. FORTON F, DE MAERTELAER V.
Rosacea-like demodicosis and papulopustular rosacea may be two phenotypes of the same disease, and pityriasis folliculorum may be their precursor: response to the comment of Tatu.
J Eur Acad Dermatol Venereol. 2018 Jul 1. doi: 10.1111/jdv.15162
PMID:299619502019 208. Forton FMN, DE MAERTELAER V.
Rosacea and Demodicosis: Little-known Diagnostic Signs and Symptoms.
Acta Derm Venereol. 2019 Jan 1;99(1):47-52. doi: 10.2340/00015555-3041.
PMID:30226528
209.Forton F, DE MAERTELAER V. .
Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case-control study.
Br J Dermatol. 2019 Feb 22. doi: 10.1111/bjd.17817. [Epub ahead of print]
PMID:0801673
2020-06-10_CvULB.docx Page 21/29 210. Goldrat O, Van Den Steen G, Gonzalez-Merino E, Dechène J, Gervy C, Delbaere A, Devreker F, De Maertelaer V, Demeestere I.
Letrozole-associated controlled ovarian hyperstimulation in breast cancer patients versus conventional controlled ovarian hyperstimulation in infertile patients: assessment of oocyte quality related biomarkers.
Reprod Biol Endocrinol. 2019 Jan 3;17(1):3. doi: 10.1186/s12958-018-0443-x.
PMID:30606204
211. Lefèvre N, Corazza F, Valsamis J, Delbaere A, De Maertelaer V, Duchateau J, Casimir G.
The Number of X Chromosomes Influences Inflammatory Cytokine Production Following Toll-Like Receptor Stimulation.
Front Immunol. 2019 May 9;10:1052. doi: 10.3389/fimmu.2019.01052. eCollection 2019.
PMID:31143188
212. Forton FMN, De Maertelaer V.
Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms.
J Eur Acad Dermatol Venereol. 2019 Sep 7. doi: 10.1111/jdv.15938. [Epub ahead of print]
PMID:31494991
213. Revenco T1, Nicodème A1, Pastushenko I1, Sznurkowska MK1, Latil M1, Sotiropoulou PA1, Dubois C1, Moers V1, Lemaire S1, de Maertelaer V2, Blanpain C3
Context Dependency of Epithelial-to-Mesenchymal Transition for Metastasis.
Cell Rep. 2019 Nov 5;29(6):1458-1468.
214. Duerinckx S, Jacquemin V, Drunat S, Vial Y, Passemard S, Perazzolo C, Massart A, Soblet J, Racapé J, Desmyter L, Badoer C, Papadimitriou S, Le Borgne YA, Lefort A, Libert F, De Maertelaer V, Rooman M, Costagliola S, Verloes A, Lenaerts T, Pirson I, Abramowicz M.
Digenic inheritance of human primary microcephaly delineates centrosomal and non-centrosomal pathways.
Hum Mutat. 2020 Feb;41(2):512-524. doi: 10.1002/humu.23948. Epub 2019 Nov 27.PMID: 31696992
215. Hauzeur JP, Lechanteur C, Baudoux E, De Maertelaer V, Pather S, Katz R, Malaise M, Ino J, Beguin Y.
Did Osteoblastic Cell Therapy Improve the Prognosis of Pre-fracture Osteonecrosis of the Femoral Head? A Randomized, Controlled Trial.
Clin Orthop Relat Res. 2019 Dec 26. doi: 10.1097/.
2020
216. F.M.N. Forton,1,* V. De Maertelaer
Treatment of rosacea and demodicosis with benzyl benzoate: effects of different doses on Demodex density and clinical symptoms .
JEADV 2020, 34, 365–369
217. F.M.N. Forton,1,* V. De Maertelaer
Effectiveness of Benzyl Benzoate Treatment on Clinical Symptoms and Demodex Density Over Time in Patients With Rosacea and Demodicosis: A Real Life Retrospective Follow-Up Study Comparing Low- And High-Dose Regimens J Dermatolog Treat. 2020 Jun 15;1-10.
2020-06-10_CvULB.docx Page 22/29
5.1.3 Articles dans des revues scientifiques nationales avec comité de lecture
1. MARTIN L, DE MAERTELAER V.
Table de valeurs (g1, g2) répondant à la courbe limitant la zone I (J) dans le diagramme (ß1,ß2) de K Pearson.
Biométrie-Praximétrie, tome XIV, vol 3 et 4 (1974) 77-80.
2.DE MAERTELAER V.
Critique du livre de P Waltham.
Biométrie-Praximétrie, tome XIV, vol 3 et 4 (1974) 87-88.
3.SMETS P, WILLEMS J, TALMON J, DE MAERTELAER V, KORNREICH F.
Methodology for the comparison of various diagnostic procedures.
Biométrie-Praximétrie XV, Vol 3 et 4 (1975) 1-35.
4.MOZIN MJ, DORCHY H, DE MAERTELAER V, ERNOULD C, LOEB H.
Food habits of 25 diabetic children in Belgium.
Acta Pediatrica Belgica 31 (1978) 49-59.
5.BROHEE D, RONDELEZ L, DE MAERTELAER V.
The effect of age on amylasemia and amylasuria related to creatininuria using a chromogenic amylase assay.
Acta Gastro-ent Belg 43 (1980) 493-501.
6.DE MAERTELAER V
Initiatives hospitalières belges à l'étranger. L'Hôpital Belge (1984) 8-10.
7.DE MAERTELAER V.
Optimalisation du choix diagnostique.
Rev Méd Brux 10 (1989) 368-370.
8.LURQUIN P, DEVULDER J, DUTERME JP, HASSID S, DE MAERTELAER V.
Proposition d'une méthode originale de calibration de l'audiométrie hautes fréquences par équations mathématiques.
Acta oto-rhino-laryngologica belg 46 (1992) 381-389.
9.BIVER F, DELVENNE V, GOLDMAN S, LUXEN A, DE MAERTELAER V, LOTSTRA F, MENDLEWICZ J No hypofrontality in schizophrenia demonstrated by position emission tomography.
Acta Psychiatr Belg 92 (1992) 261-278.
10.LEFEVRE PH, DE MAERTELAER V, BEAUTHIER J P, ROOZE M
Les mains et les paramètres morphométriques corporels, Volume des mains et identification.
Biom. Hum. et Anthropol. 22 (2004)13-23
5.1.4 Communications publiées lors de congrès ou colloques nationaux et internationaux
DE MAERTELAER V, CANTRAINE F.
Résolution matricielle des systèmes d'équations différentielles linéaires du 1er ordre à coefficients constants.
First European Biophysics Congress, 14-17 sept.1971. Baden near Vienna, Austria. (Ed. by Broda E, Locker A, Springer-lederer H) Verlag der Wiener Medizinischen Akademie.
CANTRAINE F, DE MAERTELAER V, DELCROIX C.
Modèles linéaires différentiels du premier ordre à coefficients constants. (First European Biophysics
Congress, 14-17 Sept. 1971, Baden near Vienna, Austria). (Ed. by Broda E, Locker A, Springer-lederer H) Verlag der Wiener Medizinischen Akademie.
WOLTER R, DE MAERTELAER V, DELCROIX C.
Growth hormone secretion and disappearance in dwarfism with delayed maturation. Excerpta Medica,
International Congress Series n° 236, Second International Symposium in Growth Hormone, Milan, 5-7 May (1971).
CALAY R, DE MAERTELAER V, NEVE P.
Lipids in elderly subjects with myxoedema or premyxoedema. Preliminary report. In : “ Recent Progress in diagnosis ad Treatment of hypothyroid conditions. Ed PA Bastenie, M. Bonnyns, L Van Haelst, Excerpta Medica, Int Congr Ser 529 (1980) 85-91.
MEUNIER-CARPENTIER F, SNOECK R, DE MAERTELAER V, TATERMAN J.
Serum levels of Ketoconazole and Bayer N7133 measured in humans by HPLC. Proceedings 13th International Congress of Chemotherapy,
